12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Thursday's after-market session. TRACON Pharma, Alpha Tau Medical, Avalo Therapeutics, Neoleukin Therapeutics, GRI Bio, and Assure Hldgs saw increases, while Athersys, Incannex Healthcare, Bone Biologics, Renovaro Biosciences, Cingulate, and VolitionRX experienced decreases. Q2 earnings reports were recently released for several of these companies.
August 17, 2023 | 9:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avalo Therapeutics' shares increased by 23.12% in the after-market session.
The significant increase in Avalo Therapeutics' stock price may be due to positive market sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Alpha Tau Medical's shares increased by 23.61% in the after-market session.
The significant increase in Alpha Tau Medical's stock price may be due to positive market sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
GRI Bio's stock increased by 13.2% in the after-market session. The company's Q2 earnings were released 3 days ago.
The significant increase in GRI Bio's stock price may be due to positive investor response to the company's recent Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Assure Hldgs' stock rose by 9.51% in the after-market session. The company's Q2 earnings report was released 3 days ago.
The increase in Assure Hldgs' stock price may be due to positive investor response to the company's recent Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Neoleukin Therapeutics' shares rose by 13.25% in the after-market session.
The increase in Neoleukin Therapeutics' stock price may be due to positive market sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
TRACON Pharma's stock increased by 26.8% in the after-market session. The company's Q2 earnings were released 3 days ago.
The significant increase in TRACON Pharma's stock price may be due to positive investor response to the company's recent Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Athersys' shares fell by 13.8% in the after-market session. The company's Q2 earnings were released yesterday.
The significant decrease in Athersys' stock price may be due to negative investor response to the company's recent Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Bone Biologics' shares fell by 10.67% in the after-market session.
The significant decrease in Bone Biologics' stock price may be due to negative market sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Cingulate's shares decreased by 7.53% in the after-market session. The company's Q2 earnings report was released 3 days ago.
The decrease in Cingulate's stock price may be due to negative investor response to the company's recent Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Incannex Healthcare's stock decreased by 12.41% in the after-market session.
The significant decrease in Incannex Healthcare's stock price may be due to negative market sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Renovaro Biosciences' shares decreased by 8.03% in the after-market session.
The decrease in Renovaro Biosciences' stock price may be due to negative market sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
VolitionRX's shares decreased by 6.93% in the after-market session. The company's Q2 earnings report was released 3 days ago.
The decrease in VolitionRX's stock price may be due to negative investor response to the company's recent Q2 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100